Johnson & Johnson offers US$8.9 billion payout over talc cancer claims

US pharmaceutical giant Johnson & Johnson yesterday proposed an US$8.9 billion (RM39.1 billion) settlement to resolve years-old lawsuits claiming its talcum powder products caused cancer.

The New Jersey-based company said the proposed settlement, which still needs the approval of a bankruptcy court, “will equitably and efficiently resolve all claims arising from cosmetic talc litigation.”